The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)

ACQ2 by Acquired

Inhalt bereitgestellt von Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

3M ago 1:00:35

MP3•Episode-Home

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:

The science behind what is happening in the body that causes weight loss while on Ozempic
What it was like in the 1990s and 2000s believing in a drug for a problem that the rest of the industry (including her own company) had written off
How weight loss was actually a goal from the very start — not just a side effect of diabetes medication like you often read today!

Sponsors:

Quartr

100 Episoden

#Ben Gilbert and David Rosenthal #Ben Gilbert #David Rosenthal #Trading #Entrepreneur #Business #Ben And Davids